Cardiovascular-kidney-metabolic (CKM) syndrome is a novel construct recently defined by
the American Heart Association in response to the high prevalence of metabolic and kidney …

Rates of atherosclerotic cardiovascular diseases (CVD) in the Western world have
spectacularly decreased over the past 50 years. However, a substantial proportion of high …

Importance Lipoprotein (a)(Lp [a]) is associated with atherosclerotic disease and aortic
stenosis. Lp (a) forms by bonding between apolipoprotein (a)(apo [a]) and apo B 100 …

Systemic diseases of liver origin (SDLO) are complex diseases in multiple organ systems,
such as cardiovascular, musculoskeletal, endocrine, renal, respiratory, and sensory organ …

Importance Lipoprotein (a)(Lp [a]) concentrations are a highly heritable and potential causal
risk factor for atherosclerotic cardiovascular disease (ASCVD). Recent consensus …

Therapeutic approaches to reduce atherogenic lipid and lipoprotein levels remain the most
effective and assessable strategies to prevent and treat cardiovascular disease. The …

Triglyceride-rich lipoproteins, remnant-cholesterol, and ath... : Current Opinion in Lipidology
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease …

BACKGROUND: Lipoprotein (a) is a risk factor for cardiovascular events and modifies the
benefit of PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors. Lipoprotein (a) …

Lipoprotein (a)(Lp (a)) molecule includes two protein components: apolipoprotein (a) and
apoB100. The molecule is the main transporter of oxidized phospholipids (OxPL) in plasma …

Background: Whether trends in insulin resistance changes are related to the risk of
cardiovascular disease (CVD) incidence and mortality remains unclear. We aimed to …